PUBLISHER: TechSci Research | PRODUCT CODE: 1881639
PUBLISHER: TechSci Research | PRODUCT CODE: 1881639
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Enteric Disease Testing Market, valued at USD 4.12 Billion in 2024, is projected to experience a CAGR of 4.87% to reach USD 5.48 Billion by 2030. Enteric disease testing encompasses diagnostic procedures designed to identify infections affecting the gastrointestinal tract, typically caused by bacteria, viruses, or parasites. The global market for these tests is primarily driven by the escalating prevalence of enteric infections worldwide and continuous advancements in diagnostic methodologies.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 4.12 Billion |
| Market Size 2030 | USD 5.48 Billion |
| CAGR 2025-2030 | 4.87% |
| Fastest Growing Segment | Bacterial Enteric Diseases Segment |
| Largest Market | North America |
Key Market Drivers
The increasing global burden of enteric infections significantly fuels the demand for diagnostic testing solutions. The widespread prevalence of these infections, often exacerbated by inadequate sanitation and contaminated food or water, necessitates robust surveillance and rapid identification to manage outbreaks and prevent further spread. For instance, according to the CDC's Foodborne Diseases Active Surveillance Network (FoodNet) 2023 Preliminary Data, the incidence of infections from pathogens such as Campylobacter, Cyclospora, Shiga toxin-producing E. coli (STEC), Vibrio, and Yersinia increased in 2023 compared with the 2016-2018 baseline, underscoring a persistent and growing threat. Concurrently, technological innovations in diagnostic testing are transforming the market by offering more accurate, faster, and accessible detection methods, including molecular diagnostics, immunoassays, and point-of-care platforms.
Key Market Challenges
The elevated costs associated with developing and implementing advanced diagnostic technologies present a significant impediment to the growth of the Global Enteric Disease Testing Market. These high expenditures directly limit the adoption of sophisticated testing platforms, particularly within healthcare systems operating in resource-constrained environments. Such financial barriers restrict access to accurate and rapid diagnostics, leading to delayed diagnoses and treatment for enteric infections. This directly reduces the market penetration of advanced solutions, as facilities are often compelled to prioritize less expensive, albeit potentially less effective, testing methods.
Key Market Trends
Digital health integration within diagnostic workflows is a pivotal trend, streamlining how patient data is collected, shared, and managed. This development connects diagnostic platforms with electronic health records and telehealth systems, enhancing efficiency and accessibility. According to the CDC, in April 2024, over 36,000 healthcare facilities could send electronic case reports, an increase from over 25,000 in early 2023, facilitating quicker public health responses to infectious disease threats. This interconnectivity supports comprehensive patient management and rapid epidemiological surveillance.
In this report, the Global Enteric Disease Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Enteric Disease Testing Market.
Global Enteric Disease Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: